May 6, 2021 | Securities Class Action Archive
Kehoe Law Firm, P.C. Securities Class Action Investigation On Behalf Of ChemoCentryx Investors With Significant Losses
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On May 5, 2021, a class action lawsuit was filed in United States District Court, Northern District of California, on behalf of ChemoCentryx investors who purchased, or otherwise acquired, the Company’s securities between November 26, 2019 and May 3, 2021, both dates inclusive (the “Class Period”).
According to the class action complaint, throughout the Class Period and in violation of the Exchange Act, the ChemoCentryx Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts to investors. Specifically, the ChemoCentryx Defendants, allegedly, misrepresented and/or failed to disclose to investors that (1) the study design of the Phase III ADVOCATE trial presented issues about the interpretability of the trial data to define a clinically meaningful benefit of avacopan and its role in the management of ANCA-associated vasculitis; (2) the data from the Phase III ADVOCATE trial raised serious safety concerns for avacopan; (3) these issues presented a substantial concern regarding the viability of ChemoCentryx’s NDA for avacopan for the treatment of ANCA-associated vasculitis; and (4) as a result of the foregoing, the ChemoCentryx Defendants’ public statements were materially false and misleading at all relevant times.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, CHEMOCENTRYX SECURITIES DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
May 5, 2021 | Securities Class Action Archive
Have You Suffered Losses Greater Than $75,000 Investing In Romeo Power? Kehoe Law Firm, P.C. Securities Class Action Investigation
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of ROMEO POWER, INC. (f/k/a RMG ACQUISITION CORP) (“Romeo Power” or the “Company”) (NYSE: RMO) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On April 16, 2021, a class action lawsuit was filed in United States District Court, Southern District of New York, on behalf of Romeo Power investors who purchased, or otherwise acquired, the Company’s securities between October 5, 2020 through March 30, 2021, both dates inclusive (the “Class Period”).
According to the class action complaint, unknown to investors, Romeo Power was suffering from an acute shortage of high-quality battery cells, which are key raw materials for Romeo Power’s battery packs and modules, due to supply constraints. The complaint alleges that contrary to the Romeo Power Defendants’ representations, (i) Romeo Power had only two battery cell suppliers, not four; (ii) the future potential risks that Defendants warned of concerning supply disruption or shortage had already occurred and were already negatively affecting Romeo Power’s business, operations and prospects; (iii) Romeo Power did not have the battery cell inventory to accommodate end-user demand and ramp up production in 2021; (iv) Romeo Power’s supply constraint was a material hindrance to Romeo Power’s revenue growth; and (v) Romeo Power’s supply chain for battery cells was not hedged, but, in fact, was totally at risk and beholden to just two battery cell suppliers and the spot market for their 2021 inventory. Given the supply constraint that Romeo Power was experiencing during the Class Period, the Romeo Power Defendants had no reasonable basis, according to the complaint, to represent that the Company had the ability to meet customer demand and that it would support growth in revenue in 2021.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $75,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Apr 20, 2021 | Securities Class Action Archive
1inMM Capital, LLC Investors Who Have Suffered Investment Losses Due To Alleged Ponzi Scheme Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities violations, breaches of fiduciary duty, and other claims involving Zachary J. Horwitz (“Horwitz”), 1inMM Capital, LLC (“1inmM”) and potential other parties stemming from an alleged Ponzi scheme in which investors were, over the course of more than five years, defrauded out of approximately $690 million.
On April 5, 2021, the SEC sued Horwitz and 1inMM in the United States District Court for the Central District of California for violations of the federal securities laws, alleging that, from at least March 2014 through December 2019, those defendants raised $690 million by selling promissory notes issued by 1inMM.
According to the complaint, Horwitz and 1inMM represented to investors that their funds would finance 1inMM’s acquisition and licensing of distribution rights in movies to major media companies such as Netflix and HBO. Falsely describing Netflix and HBO as “strategic partners” and fabricating fictitious movie distribution agreements and other documents, Horwitz and 1inMM promised investors returns of more than 35%.
Horwitz and 1inMM, instead, allegedly misappropriated investor monies for such improper purposes as paying putative returns on earlier investments and buying a personal residence for Horwitz for $5.7 million.
According to the SEC lawsuit, Horwitz transferred funds into his personal bank accounts with City National Bank. The alleged misconduct has resulted in investors in 1inMM promissory notes being defrauded out of hundreds of millions of dollars.
IF YOU PURCHASED PROMISSORY NOTES ISSUED BY 1inMM OR MADE INVESTMENTS WITH HORWITZ OR 1inMM AND WISH TO DISCUSS KEHOE LAW FIRM’S INVESTIGATION OR HAVE QUESTIONS ABOUT YOUR POTENTIAL LEGAL RIGHTS, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], [email protected], TO LEARN MORE ABOUT THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Apr 20, 2021 | Securities Class Action Archive
Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether certain officers and/or directors of Geron Corporation (“Geron”) (NASDAQ: GERN) breached their fiduciary duties to Geron and the Company’s shareholders.
The investigation concerns whether certain officers and/or directors of Geron, among other things, made false and misleading statements about the effectiveness of the drug imetelstat. Geron’s stock price dropped significantly when the company’s development partner, Janssen Biotech, pulled out of the imetelstat partnership on September 27, 2018, erasing hundreds of millions of dollars of shareholder value.
IF YOU HAVE HELD GERON STOCK CONTINUOUSLY SINCE AT LEAST MARCH 2018 AND WISH TO DISCUSS KEHOE LAW FIRM’S INVESTIGATION OR HAVE QUESTIONS ABOUT YOUR POTENTIAL LEGAL RIGHTS, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], [email protected], TO LEARN MORE ABOUT THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Apr 19, 2021 | Securities Class Action Archive
Emergent BioSolutions Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Emergent BioSolutions Inc. (“Emergent” or the “Company”) (NYSE: EBS) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On April 19, 2021, a class action lawsuit was filed in United States District Court for the District Of Maryland on behalf of Emergent investors who purchased, or otherwise acquired, Emergent’s common stock between July 6, 2020 and March 31, 2021, both dates inclusive (the “Class Period”).
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, EMERGENT’S COMMON STOCK DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Apr 15, 2021 | Securities Class Action Archive
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Canaan Inc. (“Canaan” or the “Company”) (NASDAQ: CAN) to determine whether the Company engaged in securities fraud or other unlawful business practices.
On April 15, 2021, a class action lawsuit was filed in United States District Court, Southern District of New York, on behalf of Canaan investors who purchased, or otherwise acquired, Canaan’s American Depositary Receipts (ADRs”) between February 10, 2021 and April 9, 2021, both dates inclusive (the “Class Period”).
According to the class action complaint, statements Canaan issued during the Class Period about the Company’s business metrics and financial prospects were materially false and misleading in that they concealed that due to ongoing supply chain disruptions and the introduction of the Company’s next-generation A12 series bitcoin mining machines – which had cannibalized sales of the older product offerings – Canaan’s sales and net revenues had significantly declined.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S ADRs DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT. 802, [email protected], [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
